ArticleJournal of clinical medicine2021

Does the Use of Peripheral Immune-Related Markers Indicate Whether to Administer Pazopanib, Trabectedin, or Eribulin to Advanced Soft Tissue Sarcoma Patients?

Eijiro Shimada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.